STA
CORZ icon

Summit Trail Advisors’s Core Scientific CORZ Stock Holding History

Summit Trail Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Buy
29,121
+2,582
+10% +$44K 0.01% 1205
2025
Q4 		$386K Sell
26,539
-6,818
-20% -$119K 0.01% 1152
2025
Q3 		$598K Buy
33,357
+221
+0.7% +$3.24K 0.01% 1022
2025
Q2 		$566K Sell
33,136
-16,199
-33% -$162K 0.01% 692
2025
Q1 		$357K Buy
+49,335
New +$562K 0.01% 292
2024
Q3 		– Sell
-694,079
Closed -$4.81M – 724
2024
Q2 		$4.81M Buy
+694,079
New +$3.55M 0.13% 69

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Summit Trail Advisors's CORZ Position: Q1 2026 in Review

Summit Trail Advisors increased its Core Scientific (CORZ) stake by 9.7% in Q1 2026, buying an estimated $44K and bringing the position to 29,121 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #1205.

Summit Trail Advisors first reported a position in CORZ in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.81M in Q2 2024. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • Summit Trail Advisors held 29,121 shares of Core Scientific worth $436K as of Q1 2026.
  • Summit Trail Advisors bought 2,582 Core Scientific shares in Q1 2026, an estimated $44K.
  • Core Scientific made up 0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #1205 holding.
  • Summit Trail Advisors first reported a position in Core Scientific in Q2 2024 and has held it in 6 quarters since.
  • Summit Trail Advisors's Core Scientific position peaked at $4.81M in Q2 2024.
  • 386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.